Medical Devices

Houston founder Dr. Bre Hayward is using her clinical expertise to redefine multicultural beauty with Baby Hair®, a brand built on scalp science and community.

Pioneers of IVF technology are launching a clinical skincare program, aiming to merge cellular science with holistic patient support in fertility clinics.

Distalmotion's smaller, cost-effective DEXTER system is challenging market giants by making robotic surgery practical for ambulatory surgery centers.

With new CEO Andrew Zeringue, Theromics aims to tackle cancer recurrence with its HeatSYNC gel, a novel approach in the booming ablation market.

A breakthrough NAMI microencapsulation tech ensures probiotics survive stomach acid, promising a new standard of health and wellness for cats and dogs.

A non-invasive therapy boasts up to 91% success for chronic pain, but patients often face a major hurdle: paying for the promising treatment themselves.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

In a landmark shift, the FDA authorized flavored e-cigarettes from Glas, betting on new device-locking technology to prevent youth use amid fierce criticism.

A new advanced sacral dressing aims to improve patient comfort, accelerate healing, and reduce the immense burden on caregivers and healthcare systems.

Millions of Americans focus on diet and exercise for longevity, but new research reveals a shocking oversight. Is ignoring our hearing our biggest health mistake?

Massachusetts has approved a groundbreaking on-site technology that turns hazardous medical waste into recyclable material, disrupting the traditional disposal industry.

PSHSA launches Intelligent Safety™, a pioneering AI division aiming to revolutionize health and wellbeing for public workers through human-centred technology.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

For a teen with rare genetic conditions, a sunken chest was a daily struggle. A pioneering surgery didn't just fix it—it gave him a new life.

Neurovascular giant Balt deepens its Irvine roots with a new facility, a $400M investment, and plans for 700 jobs to accelerate stroke-fighting tech.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

Endologix expands its vascular intervention portfolio by acquiring the Pounce Thrombectomy System, a mechanical device poised to change peripheral clot removal.

With a novel two-in-one device and a $41M funding boost, Cagent Vascular is poised to challenge the standard of care for complex calcified arteries.

A top scientific honor for Dr. Mariano Garcia-Blanco validates a new approach to autoimmune disease, targeting a genetic trait in 50% of the population.

New research on the gut-brain axis and smarter antibiotic use is transforming veterinary medicine, moving from theory to practice for healthier pets.